Penn Medicine Provider
Family Medicine
Kevin Kline, MD
He/Him
4.9
(498)
LGBTQ+ affirming provider
Additional provider information
Accepting new patients
Sees patients of all ages

About me

  • Director of LGBTQ+ Health, Department of Family Medicine and Community Health
  • Medical Director for LGBTQ+ Health, Penn Medicine
  • Assistant Professor of Clinical Family Medicine and Community Health

Education and training

  • Medical School: Saint Louis University - School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

498 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
great doctor
May 2025
5.0
5.0
caring and professional
May 2025
5.0
5.0
dr kline was friendly-professional, knowledgeable.
May 2025
5.0
5.0
dr kline is very professional but also kind-he takes time to answer questions and put me at ease, and i feel very comfortable discussing things with him.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kline is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hodan R, Rodgers-Fouche L, Chittenden A, Dominguez-Valentin M, Ferriss J, Gima L, Hamnvik OR, Idos GE, Kline K, Koeller DR, Long JM, McKenna D, Muller C, Thoman M, Wintner A, Bedrick BS; Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer , Fam Cancer, 22(4): 2023,437-448